Dr. Michael Ross withdrew from the federal vaccine safety advisory committee Wednesday, two weeks after Health and Human ...

A key vaccine-focused committee of the Centers for Disease Control and Prevention met Wednesday despite bipartisan ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

After a chaotic two weeks that saw the ousting of the 17 standing members of the CDC's Advisory Committee on Immunization Practices, Health Secretary Robert F. Kennedy's newly appointed advisors are ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers began their first meeting Wednesday under intense scrutiny ...

The newly appointed members of the CDC’s influential vaccine committee meet Wednesday and Thursday under an unusually rapid ...

Nearly three-quarters of infants were immunized against respiratory syncytial virus through maternal vaccination or ...

Moderna Inc. (NASDAQ:MRNA) is one of the best mid cap growth stocks to invest in now. On June 12, the US FDA expanded the ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...